Objectives: The author decided to treat damaged skin emanating from burns and dermal induced vascular occlusion (devoid of bleeding and release of growth factors, signal messengers etc.) with potential to dermal scarring with ethical stem cells, signal messengers (USCs), growth factors (PRP) and an activating source (LLLT) to see whether it accelerated recovery and prevented scarring. I can see no literature references to whether this was done before
Introduction: : LLLT can either act directly on cells or initiate the release of specific mediators. Epithelial mesenchymal transition (EMT) occurs when epithelial cells lose their characteristics and become mesenchymal. These mesenchymal cells can return to an epithelial phenotype by mesenchymal-epithelial transition.
Materials / method: Adipose Stem Cells initially harvested from VASER
LED lamps for light therapy were provided by Omnilux, Birmingham UK, who developed in partnership for PDT with Cancer Research UK
Umbilical Stem Cells were provided without financial benefit from CellResearchCorp based in Singapore
Laser resurfacing provided by ActiveFx by Lumenis
Results: LLLT can either act directly on cells or initiate the release of specific mediators. Epithelial mesenchymal transition (EMT) occurs when epithelial cells lose their characteristics and become mesenchymal. These mesenchymal cells can return to an epithelial phenotype by mesenchymal-epithelial transition.
Conclusion: Dermal papilla cells irradiated by 633nm red light enhance keratinocyte proliferation, suggesting enhanced epithelial-mesenchymal interaction. The author advances theory that this process advances the production of epidermal tissue in the presence of a cell source and autologous and external signal messengers in patients traumatised in the absence of normal bleeding repair
Declaraciones
¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No
¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No
¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No
¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No
Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.